Prognosis of Postoperative Cholangitis Following Pancreaticoduodenectomy: A Single-Centered Retrospective Cohort Study
- PMID: 38883123
- PMCID: PMC11179028
- DOI: 10.7759/cureus.60392
Prognosis of Postoperative Cholangitis Following Pancreaticoduodenectomy: A Single-Centered Retrospective Cohort Study
Abstract
Introduction Postoperative cholangitis (POC) after pancreaticoduodenectomy is a serious complication. However, the prognostic factors are unclear. We aimed to investigate the relationships between biliary lesions and prognosis in patients with cholangitis after pancreaticoduodenectomy. Methods We conducted a single-centered retrospective cohort study. The unit of analysis was hospital admissions. We extracted patients who underwent pancreaticoduodenectomy from 2010 to 2018, and have a record of hospitalization of cholangitis from January 2010 to October 2019. We defined the bile duct lesions as the presence of one of the following: biliary stent, intrahepatic bile duct dilatation, intrahepatic bile duct stones, or common bile duct stones on imaging studies. The primary outcome was the treatment failure of POC. We defined the failure as a composite outcome of death within 30 days of initiation of treatment, relapse during treatment, or recurrence of cholangitis. We used logistic regression analysis to examine the association between the presence of bile duct lesions and the occurrence of outcomes. Results Of 154 admissions included in the present study, 120 cases (77.9%) were with bile duct lesions. Bile duct lesions were associated with the treatment failure (crude odds ratio [OR] 2.56, 95% confidence intervals [CI] 1.08 to 6.32; adjusted OR 2.81, 95%CI 1.08 to 7.34). Conclusions Clinicians should follow the patient of POC with bile duct lesions on imaging carefully because of the high risk of treatment failure, especially for recurrence. Further studies are warranted to confirm our results.
Keywords: choledochojejunostomy; pancreaticoduodenectomy; postoperative cholangitis; prognostic factor; retrospective cohort study.
Copyright © 2024, Yamamoto et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

Similar articles
-
Hepaticoplasty prevents cholangitis after pancreaticoduodenectomy in patients with small bile ducts.Int J Surg. 2016 Nov;35:7-12. doi: 10.1016/j.ijsu.2016.08.003. Epub 2016 Aug 6. Int J Surg. 2016. PMID: 27506272
-
Novel choledochojejunostomy technique "T-shaped anastomosis" for preventing the development of postoperative cholangitis in pancreatoduodenectomy: A propensity score matching analysis.Ann Gastroenterol Surg. 2023 Sep 28;8(2):301-311. doi: 10.1002/ags3.12744. eCollection 2024 Mar. Ann Gastroenterol Surg. 2023. PMID: 38455496 Free PMC article.
-
Effect of stent placement on stone recurrence and post-procedural cholangitis after endoscopic removal of common bile duct stones.Korean J Intern Med. 2021 Mar;36(Suppl 1):S27-S34. doi: 10.3904/kjim.2020.060. Epub 2020 Aug 24. Korean J Intern Med. 2021. PMID: 32829571 Free PMC article.
-
Treatment of chronic pancreatitis complicated by obstruction of the common bile duct or duodenum.World J Surg. 1990 Jan-Feb;14(1):59-69. doi: 10.1007/BF01670547. World J Surg. 1990. PMID: 2407039 Review.
-
Roux-en-Y choledochojejunostomy versus duct-to-duct biliary anastomosis in liver transplantation for primary sclerosing cholangitis: a meta-analysis.Transplant Proc. 2013 Jul-Aug;45(6):2263-71. doi: 10.1016/j.transproceed.2013.01.066. Transplant Proc. 2013. PMID: 23953538 Review.
References
-
- Cholangitis following biliary-enteric anastomosis: a systematic review and meta-analysis. Birgin E, Téoule P, Galata C, Rahbari NN, Reissfelder C. Pancreatology. 2020;20:736–745. - PubMed
-
- Risk factors for pancreatic fistula grade C after pancreatoduodenectomy: a large prospective, multicenter Japan-Taiwan collaboration study. Hirono S, Shimokawa T, Nagakawa Y, et al. J Hepatobiliary Pancreat Sci. 2020;27:622–631. - PubMed
LinkOut - more resources
Full Text Sources